Bharat Parenterals Q4 results : loss at ₹0.3Cr, Revenue increased by 33.06% YoY

Bharat Parenterals Q4 Results Live : Bharat Parenterals declared their Q4 results on 22 May, 2024, showcasing a significant increase in revenue by 33.06% year-on-year. However, the company reported a loss of ₹0.3 crore for the quarter.

In the previous fiscal year during the same period, Bharat Parenterals had recorded a profit of ₹2.48 crore, indicating a downturn in the current quarter's performance.

The company experienced a 13.37% growth in revenue compared to the previous quarter, indicating a positive trend in the business.

On the expense front, the Selling, general & administrative expenses saw a notable increase of 25.05% quarter-on-quarter and 17.31% year-on-year, which could have impacted the overall profitability.

The operating income took a hit, decreasing by 159.92% quarter-on-quarter and 159.54% year-on-year, reflecting operational challenges faced by Bharat Parenterals.

Earnings Per Share (EPS) for Q4 stood at ₹-0.62, marking a significant decline of 114.62% year-on-year, pointing towards a decrease in the company's profitability per share.

Despite the challenges, Bharat Parenterals has shown varying returns in different time frames, with a -3.39% return in the last week, a remarkable 160.57% return in the last 6 months, and a solid 83.53% year-to-date return.

Currently, Bharat Parenterals boasts a market capitalization of ₹865.27 crore, with a 52-week high/low of ₹1824.7 and ₹330 respectively, indicating fluctuations in the company's stock performance.